ATE326226T1 - Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen - Google Patents

Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen

Info

Publication number
ATE326226T1
ATE326226T1 AT03405852T AT03405852T ATE326226T1 AT E326226 T1 ATE326226 T1 AT E326226T1 AT 03405852 T AT03405852 T AT 03405852T AT 03405852 T AT03405852 T AT 03405852T AT E326226 T1 ATE326226 T1 AT E326226T1
Authority
AT
Austria
Prior art keywords
methyltestosterone
human papillomavirus
treat human
papillomavirus infections
infections
Prior art date
Application number
AT03405852T
Other languages
English (en)
Inventor
Liang Youguo
Xie Xiaohong
Xie Zhiyu
Original Assignee
Liang Youguo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liang Youguo filed Critical Liang Youguo
Application granted granted Critical
Publication of ATE326226T1 publication Critical patent/ATE326226T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03405852T 2002-12-23 2003-12-01 Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen ATE326226T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021280789A CN1168449C (zh) 2002-12-23 2002-12-23 抗人乳头瘤病毒感染的药物

Publications (1)

Publication Number Publication Date
ATE326226T1 true ATE326226T1 (de) 2006-06-15

Family

ID=4745919

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03405852T ATE326226T1 (de) 2002-12-23 2003-12-01 Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen

Country Status (5)

Country Link
US (1) US20040191311A1 (de)
EP (1) EP1433481B1 (de)
CN (1) CN1168449C (de)
AT (1) ATE326226T1 (de)
DE (1) DE60305279D1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1168449C (zh) * 2002-12-23 2004-09-29 梁有国 抗人乳头瘤病毒感染的药物
SI2204374T1 (sl) * 2003-12-30 2012-09-28 Gilead Sciences Inc Nukleozidni fosfonati in njihovi analogi za zdravljenje HPV-infekcij
US20090215731A1 (en) 2005-10-19 2009-08-27 Chavah Pty Ltd. Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
AU2012200290B2 (en) * 2005-10-19 2014-08-21 Havah Therapeutics Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
RU2494732C1 (ru) * 2012-07-03 2013-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная академия ветеринарной медицины" Способ коррекции минерального обмена у коров в условиях биогеохимической провинции
EP3209301B1 (de) 2014-10-22 2023-06-07 Havah Therapeutics Pty Ltd Verfahren zur reduzierung der mammografischen brustdichte und/oder des brustkrebsrisikos
AU2016343297A1 (en) 2015-10-22 2018-05-10 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
CN114599369A (zh) 2019-06-03 2022-06-07 哈瓦赫治疗有限公司 用于递送雄激素剂和芳香酶抑制剂的药物制剂和系统以及使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3514724A1 (de) * 1985-04-24 1986-10-30 Albin F. Dr. 4200 Oberhausen Jereb Salbe zur verbeugung und behandlung von augen- und hauterkrankungen
US4605648A (en) * 1985-08-15 1986-08-12 Price E Pendleton Treatment of Herpes Simplex viruses
US20030060435A1 (en) * 1994-05-31 2003-03-27 Serge Carillo Method of cancer treatment by p53 protein control
CN1168449C (zh) * 2002-12-23 2004-09-29 梁有国 抗人乳头瘤病毒感染的药物

Also Published As

Publication number Publication date
EP1433481A1 (de) 2004-06-30
EP1433481B1 (de) 2006-05-17
CN1424040A (zh) 2003-06-18
CN1168449C (zh) 2004-09-29
DE60305279D1 (de) 2006-06-22
US20040191311A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE292971T1 (de) (s,s)-reboxetin zur behandlung von peripheren neuropathien
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
WO2006015035A8 (en) Useful compounds for hpv infection
DE50310516D1 (de) Fredericamycin-derivate
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO20061122L (no) 2-(Quinoksalin-5-ylsuflonylamino)-benzamid forbindelser som CCK2 modulatorer
DE60230759D1 (de) Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE451921T1 (de) Phenylindole zur behandlung von hiv
NO20055741L (no) Nye kjemiske forbindelser
ATE521361T1 (de) Verfahren zur behandlung von gebärmutterhalskrebs
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
ATE326226T1 (de) Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
DE60219940D1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
EA200600115A1 (ru) Производные 2-аминобензойной кислоты

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties